Rockwell Medical Full Year 2023 Earnings: EPS Beats Expectations
Rockwell Medical (NASDAQ:RMTI) Full Year 2023 Results
Key Financial Results
Revenue: US$83.6m (up 15% from FY 2022).
Net loss: US$8.59m (loss narrowed by 54% from FY 2022).
US$0.37 loss per share (improved from US$1.31 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Rockwell Medical EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 10%.
The primary driver behind last 12 months revenue was the United States segment contributing a total revenue of US$74.3m (89% of total revenue). Notably, cost of sales worth US$74.9m amounted to 90% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$12.1m (70% of total expenses). Explore how RMTI's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 7.9% p.a. on average during the next 2 years, compared to a 7.9% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are up 17% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 4 warning signs for Rockwell Medical (2 are concerning!) that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
